NDC Package 11014-0147-1 Topiramate

Capsule, Extended Release - View Billable Units, 11-Digit Format, RxNorm

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
11014-0147-1
Package Description:
1 BAG in 1 CONTAINER / 252459 CAPSULE, EXTENDED RELEASE in 1 BAG
Product Code:
Non-Proprietary Name:
Topiramate
Substance Name:
Topiramate
Usage Information:
Topiramate is used alone and with other medications to prevent and control seizures (epilepsy). It is also used to prevent migraine headaches. Topiramate belongs to a class of drugs known as anticonvulsants.
11-Digit NDC Billing Format:
11014014701
Product Type:
Drug For Further Processing
Labeler Name:
Catalent Pharma Solutions, Llc
Dosage Form:
Capsule, Extended Release - A solid dosage form in which the drug is enclosed within either a hard or soft soluble container made from a suitable form of gelatin, and which releases a drug (or drugs) in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form.
Active Ingredient(s):
Sample Package:
N/A
Marketing Category:
DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
Start Marketing Date:
07-07-2014
Listing Expiration Date:
12-31-2024
Exclude Flag:
N
Unfinished Product:
Yes
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Other Product Packages

The following packages are also available for this product:

NDC Package CodePackage Description
11014-0147-21 BAG in 1 CONTAINER / 491803 CAPSULE, EXTENDED RELEASE in 1 BAG

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 11014-0147-1?

The NDC Packaged Code 11014-0147-1 is assigned to an UNFINISHED drug package of 1 bag in 1 container / 252459 capsule, extended release in 1 bag of Topiramate, drug for further processing labeled by Catalent Pharma Solutions, Llc. The product's dosage form is capsule, extended release and is administered via form.

Is NDC 11014-0147 included in the NDC Directory?

Yes, Topiramate is an UNFINISHED PRODUCT with code 11014-0147 that is active and included in the NDC Directory. The product was first marketed by Catalent Pharma Solutions, Llc on July 07, 2014 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 11014-0147-1?

The 11-digit format is 11014014701. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-4-111014-0147-15-4-211014-0147-01